Drug intelligence / Profile preview

budesonide + terbutaline

Development stage
Unknown
Lead developer
AstraZeneca
Modality
Small Molecules
Administration
Inhalation, Oral, Intravenous, Subcutaneous, Intranasal, Rectal
01

Overview

Budesonide + terbutaline is a combination of two small molecule drugs used primarily for respiratory conditions. Budesonide is a synthetic glucocorticoid corticosteroid that acts as an anti-inflammatory agent, reducing inflammation in the airways and other tissues. Terbutaline is a selective beta-2 adrenergic receptor agonist that functions as a bronchodilator by relaxing smooth muscle in the bronchial tubes, thereby improving airflow and relieving symptoms such as wheezing and shortness of breath. This combination may be considered for use in asthma or chronic obstructive pulmonary disease (COPD), leveraging both anti-inflammatory and bronchodilatory effects[1][2][5].

Brand names
AirsupraBreynaBreztriCortimentEntocortEohiliaPulmicortPulmicort TurbuhalerRhinocortSymbicortTarpeyoUcerisBricanyl
02

Targets

GR (Glucocorticoid receptor)ADRB2 (β2)

Beyond the preview

Go deeper on budesonide + terbutaline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on budesonide + terbutaline.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call